SAVANNAH RESOURCES PLC
SAV | IL
Overview
Corporate Details
- ISIN(s):
- GB00B647W791
- LEI:
- 213800UCK16HW5KKGP60
- Country:
- United Kingdom
- Address:
- SALISBURY HOUSE, EC2M 5PS LONDON
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Scancell Holdings PLC, founded in 1997, develops innovative immunotherapies for cancer and infectious diseases.Ê Its mission is to create therapeutic cancer vaccines using vaccine platforms (Moditope, ImmunoBody) and monoclonal antibody platforms (GlyMab, AvidiMab) to stimulate the patient's immune system.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-28 08:00 |
Regulatory News Service
Investor Presentation
|
English | 15.1 KB | |
| 2025-07-24 08:00 |
Regulatory News Service
Appointment of Project Finance Advisor
|
English | 20.6 KB | |
| 2025-07-10 08:00 |
Investor Presentation
New Corporate Presentation
|
English | 15.0 KB | |
| 2025-07-02 08:00 |
Capital/Financing Update
Retail Offer increases Fundraise to £4.8 million
|
English | 28.3 KB | |
| 2025-06-27 08:20 |
Share Issue/Capital Change
Result of Accelerated Bookbuild and Subscription
|
English | 54.0 KB | |
| 2025-06-26 18:00 |
Share Issue/Capital Change
RetailBook Offer
|
English | 38.1 KB | |
| 2025-06-26 17:51 |
Share Issue/Capital Change
Proposed Fundraise
|
English | 147.2 KB | |
| 2025-06-18 14:27 |
Transaction in Own Shares
PDMR Notification
|
English | 27.8 KB | |
| 2025-06-10 13:04 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 24.3 KB | |
| 2025-05-29 08:02 |
Regulatory News Service
More encouraging results in third batch of assays
|
English | 270.6 KB | |
| 2025-05-14 08:00 |
Regulatory News Service
Research Initiation by Canaccord Genuity
|
English | 15.3 KB | |
| 2025-04-22 09:47 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 39.3 KB | |
| 2025-03-27 08:00 |
Regulatory News Service
Encouraging first assays from Phase 2 drilling
|
English | 185.0 KB | |
| 2025-03-25 16:58 |
Regulatory News Service
BLP designated as Strategic Project under EU CRMA
|
English | 22.0 KB | |
| 2025-02-21 08:00 |
Regulatory News Service
Restart of fieldwork at Project
|
English | 17.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Adocia | France | ADOC | |
|
Advicenne | France | ALDVI | |
|
Aelis Farma | France | AELIS | |
|
Aker BioMarine | Norway | AKBM | |
|
ALK-Abelló | Denmark | ALK | |
|
Alligator Bioscience | Sweden | ATORX | |
|
Alvotech Holdings S.A | Luxembourg | ALVO | |
|
AlzeCure Pharma | Sweden | ALZCUR | |
|
Alzinova AB | Sweden | ALZ | |
| ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. | Türkiye | ANGEN |